ATLAS ARTERIA (ALX)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ALX - ATLAS ARTERIA

FNArena Sector : Infrastructure & Utilities
Year End: December
GICS Industry Group : Transportation
Debt/EBITDA: 26.84
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Atlas Arteria, formerly known as Macquarie Atlas Roads, is a global owner, operator and developer of toll roads. It was created and listed in 2010 following the restructuring of the Macquarie Infrastructure Group.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$4.96

03 Feb
2025

-0.110

OPEN

$5.00

-2.17%

HIGH

$5.04

1,672,013

LOW

$4.94

TARGET
$5.318 7.2% upside
OTHER COMPANIES IN THE SAME SECTOR
AGL . AIA . APA . CEN . DBI . DBI . GNE . GNP . MEZ . ORG . SRJ . TCL .
FNARENA'S MARKET CONSENSUS FORECASTS
ALX: 1
Title FY22
Actual		 FY23
Actual		 FY24
Forecast		 FY25
Forecast
EPS (cps) xxx 17.7 34.5 xxx
DPS (cps) xxx 40.0 40.0 xxx
EPS Growth xxx - 20.5% 95.4% xxx
DPS Growth xxx 0.0% 0.0% xxx
PE Ratio xxx N/A 14.3 xxx
Dividend Yield xxx N/A 8.1% xxx
Div Pay Ratio(%) xxx 226.4% 115.8% xxx

Dividend yield today if purchased 3 years ago: 5.84%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 8.08

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 24/09 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx17.7
DPS All xxxxxxxxxxxxxxx40.0
Sales/Revenue xxxxxxxxxxxxxxx134.0 M
Book Value Per Share xxxxxxxxxxxxxxx429.8
Net Operating Cash Flow xxxxxxxxxxxxxxx713.6 M
Net Profit Margin xxxxxxxxxxxxxxx191.27 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx4.03 %
Return on Invested Capital xxxxxxxxxxxxxxx3.21 %
Return on Assets xxxxxxxxxxxxxxx3.13 %
Return on Equity xxxxxxxxxxxxxxx4.03 %
Return on Total Capital xxxxxxxxxxxxxxx-0.06 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx132.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx102 M
Long Term Debt xxxxxxxxxxxxxxx1,619 M
Total Debt xxxxxxxxxxxxxxx1,721 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx305 M
Price To Book Value xxxxxxxxxxxxxxx1.34

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx0.8 M
Capex % of Sales xxxxxxxxxxxxxxx0.60 %
Cost of Goods Sold xxxxxxxxxxxxxxx118 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx22 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx5,547 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.4

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

30/01/2025

1

Buy

$5.80

16.94%

Atlas Arteria's 4Q 2024 reported traffic metrics revealed a recovery across the company's markets, including light vehicle traffic improving for both APRR in France and Chicago Skyway in the US, the Citi analyst observes.

Dulles Greenway reported robust growth of 9% in the quarter versus a contraction of -5% year to date, the broker notes.

While acknowledging the recovery in traffic levels is positive for Atlas Arteria, Citi highlights the "bigger driver" of cash flows and distributions is a softer AUD.

The broker raises EPS estimates by 2.2% and 5.5% for FY25/FY26, respectively, pointing to the risk of additional taxes from France impacting FY25 distributions.

Buy/High Risk rating retained. Citi believes on an 8% dividend yield the stock is offering value. Target price of $5.80 is unchanged.

FORECAST
Citi forecasts a full year FY24 dividend of 40.00 cents and EPS of 15.10 cents.
Citi forecasts a full year FY25 dividend of 40.00 cents and EPS of 16.00 cents.

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

03/02/2025

-1

No Rating

-

Jarden notes Atlas Arteria's 4Q24 update showed traffic and revenue continue to improve with a weighted average of 2.9% and 6.9% for traffic and revenue growth respectively.

Based on FY24 distribution guidance of 40c, the company currently trades on an 8.2% distribution yield, equating to 370bps spread over Australian 10-yr bond yield. Listed peer Transurban ((TCL)) with 4.9% distribution yield trades at a narrower 17bps spread but Atlas' yield reflects its higher risk profile, Jarden highlights.

Atlas' traffic result has minimal implication for Transurban, the broker notes. Jarden is under research restriction, so no rating and no target price.
Access Extra Coverage Research History >

ALX STOCK CHART

FNArena News on ALX

1
Australian Broker Call *Extra* Edition – Feb 03, 2025

Feb 03 2025 - Daily Market Reports
2
Rudi’s View: Cochlear, Guzman y Gomez, SiteMinder, Wesfarmers & Xero

Jan 30 2025 - Rudi's View
3
Rudi’s View: Feb Season’s Best Buys & Key Picks

Jan 23 2025 - Rudi's View
4
Rudi’s View: Best Buys & Convictions For 2025

Jan 16 2025 - Rudi's View
5
Rudi’s View: Final Best Buys & Conviction Ideas

Dec 23 2024 - Rudi's View

Latest Infrastructure & Utilities News

1
AGL Energy: Data Centres To The Rescue?

Nov 07 2024 - Australia
2
Origin Energy Surprises To The Downside

Aug 20 2024 - Australia
3
Uptrend In Place For Origin Energy

Jul 30 2024 - Technicals
4
Can Gentrack Live Up To Its Shareprice?

Jul 11 2024 - Small Caps
5
AGL Energy Shares Eyeing $12 Target

Jun 25 2024 - Technicals
6
Next Week At A Glance – 10-14 Jun 2024

Jun 07 2024 - Weekly Reports
7
ESG Focus: The Little Big Things – 15-11-2023

Nov 15 2023 - ESG Focus
8
ESG Focus: ESG-Linked Remuneration Now In Focus

Oct 19 2023 - ESG Focus
9
Book Excerpt: Need To Know About Investing In Infrastructure

Jun 09 2023 - Book Reviews
10
The Prudence Of Infrastructure In A Recession

Jun 09 2023 - International